Nelabin- Nelarabine Injection 250mg/50m

Get a Price/Quote

Nelabin- Nelarabine Injection 250mg/50m Specification

Drug Type
Injection

Physical Form
Liquid

Function
Anti-Cancer

Suitable For
Suitable For All

About Nelabin- Nelarabine Injection 250mg/50m

Nelarabine injection is used to treat specific types of cancer called T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). This medicine is usually given to patients who have already received at least two other cancer medicines.

Nelarabine is a prodrug of arabinosylguanine nucleotide triphosphate (araGTP), a type of purine nucleoside analog, which causes inhibition of DNA synthesis and cytotoxicity. Pre-clinical studies suggest that T-cells are particularly sensitive to nelarabine. In October 2005, it was approved by the FDA for acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma that has not responded to or has relapsed following treatment with at least two chemotherapy regimens. It was later approved in the European Union in October 2005.

Tell us about your requirement